369
Participants
Start Date
December 31, 2008
Primary Completion Date
May 31, 2009
Study Completion Date
May 31, 2009
AZD7325
4 tablets and 1 capsule taken twice a day for 28 days
AZD7325
4 tablets and 1 capsule taken twice a day for 28 days
Lorazepam
4 tablets and 1 capsule taken twice a day for 28 days
Placebo
4 tablets and 1 capsule taken twice a day for 28 days
Research Site, Mesa
Research Site, Little Rock
Research Site, Carson
Research Site, Escondido
Research Site, Glendale
Research Site, Irvine
Research Site, Redlands
Research Site, Riverside
Research Site, Sherman Oaks
Research Site, Fort Lauderdale
Research Site, Fort Myers
Research Site, Gainsville
Research Site, Hallandale
Research Site, Jacksonville
Research Site, Maitland
Research Site, Orlando
Research Site, St. Petersburg
Research Site, Tampa
Research Site, West Palm Beach
Research Site, Atlanta
Research Site, Hoffman Estates
Research Site, Oak Brook
Research Site, Schaumburg
Research Site, Lafayette
Research Site, Terre Haute
Research Site, Shreveport
Research Site, Glen Burnie
Research Site, Westminster
Research Site, Braintree
Research Site, Piscataway
Research Site, Cedarhurst
Research Site, New York
Research Site, Staten Island
Research Site, Raleigh
Research Site, Cincinnati
Research Site, Cleveland
Research Site, Dayton
Research Site, Willoughby
Research Site, Oklahoma City
Research Site, Eugene
Research Site, Salem
Research Site, Allentown
Research Site, Philadelphia
Research Site, Charleston
Research Site, Bartlett
Research Site, Austin
Research Site, Dallas
Research Site, San Antonio
Research Site, Wichita Falls
Research Site, Richmond
Research Site, Seattle
Lead Sponsor
AstraZeneca
INDUSTRY